Related Experiment Video

Updated: Jun 22, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

[Uremic and haemolytic syndrome in children: study of 17 cases]

Jalel Chemli1, Saïda Hassayoun, Saoussen Krid

  • 1Service de pédiatrie du CHU Sahloul, Sousse, Tunisie.

La Tunisie Medicale
|May 28, 2009
PubMed

Insights

Hemolytic Uremic Syndrome (HUS) is a rare but serious cause of acute renal insufficiency in children. Treatment is specific for atypical HUS, but complications remain a significant risk.

Area of Science:

  • Pediatric Nephrology
  • Hematology
  • Critical Care Medicine

Context:

  • Hemolytic Uremic Syndrome (HUS) is a leading cause of acute renal insufficiency in children.
  • Despite its rarity, HUS presents significant diagnostic and management challenges.

Purpose:

  • To analyze the clinical features and outcomes of Hemolytic Uremic Syndrome (HUS) in pediatric patients.
  • To evaluate the effectiveness of different treatment modalities for HUS.

Summary:

  • A retrospective study of 17 pediatric HUS cases (1996-2003) revealed diverse clinical presentations, including typical and atypical forms.
  • Extra-renal manifestations were common, necessitating interventions like blood transfusions and dialysis. Plasma therapy showed short-term benefits in some cases.
  • Outcomes varied, with some patients recovering renal function, others progressing to end-stage renal disease, and a significant mortality rate, particularly in atypical HUS.

Impact:

  • This study highlights the serious nature of HUS in children and the ongoing risk of complications.
  • Findings underscore the importance of early diagnosis and tailored treatment strategies, especially for atypical HUS.
  • The data provides valuable insights for clinicians managing pediatric HUS, informing prognosis and therapeutic decisions.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...